RxDoctor Payments Data

Shannon Heaton

Nurse Practitioner · Asheboro, NCNPI 1750957239

Payments from drug & device makers

$5,972in general payments, 2019–2025

Across 291 payments — averaging $20.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$599
  • Novo Nordisk$515
  • Lilly USA, LLC$421
  • Bayer$408
  • Astellas Pharma US Inc$294
  • GSK$274
  • plus $3K from 52 others

What the payments were for

  • Food & beverage$5,81197%
  • Education$1613%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie38$599
Novo Nordisk32$515
Lilly USA, LLC24$421
Bayer18$408
Astellas Pharma US Inc11$294
GSK11$274
Boehringer Ingelheim14$265
AstraZeneca11$255
Pfizer9$253
Amgen11$178
Johnson & Johnson4$175
Takeda Pharmaceuticals U.S.A., Inc.8$153
E.r. Squibb & Sons, L.L.C.2$142
Pharmaessentia USA Corporation2$140
Beigene USA, Inc.2$139
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC7$118
Daiichi Sankyo Inc.5$115
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$107
Sanofi-aventis U.S. LLC5$101
Sumitomo Pharma America, Inc.5$95
Novartis4$94
Merck4$81
Ironwood Pharmaceuticals, Inc4$68
Xeris Pharmaceuticals, Inc.4$64
Dexcom, Inc.3$53
Pharmacosmos Therapeutics Inc.3$52
Eisai Inc.2$51
Bristol Myers Squibb2$48
Regeneron Healthcare Solutions, Inc.2$45
Esperion Therapeutics, Inc.3$42
Idorsia Pharmaceuticals US Inc2$36
Biohaven Pharmaceutical Holding Company Ltd.2$35
Exact Sciences2$34
Jazz Pharmaceuticals Inc.2$33
Incyte Corporation2$32
Genentech USA, Inc.2$31
Amarin Pharma, Inc.2$30
Otsuka America Pharmaceutical, Inc.2$28
Phathom Pharmaceuticals, Inc.1$25
Geron Corporation1$25
Deciphera Pharmaceuticals Inc.1$23
Beone Medicines USA, Inc.1$23
Puma Biotechnology, Inc.1$22
Tempus AI, Inc1$21
Exelixis Inc.1$21
Taiho Oncology, Inc.1$20
Biohaven Pharmaceuticals, Inc.1$20
AVEO Pharmaceuticals, Inc.1$19
Acrotech Biopharma Inc.1$19
Array Biopharma Inc1$19
Gilead1$18
Kyowa Kirin, Inc.1$16
Shield Therapeutics Inc1$15
ADC Therapeutics America, Inc.1$15
Sobi, Inc1$14
Novocure Inc.1$14
Sunovion Pharmaceuticals Inc.1$14
Corium, LLC1$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,972 in reported general payments places this provider in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$15,566
Medicare patients
129
Services billed
181

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide15$16,558
Fluticasone Propionate46$897
Pantoprazole Sodium33$465
Oxycodone Hcl11$464
Omeprazole31$441
Rosuvastatin Calcium37$314
Atorvastatin Calcium14$228
ClopidogrelClopidogrel Bisulfate14$226
Letrozole12$214
Levothyroxine Sodium25$196
Lisinopril19$179
Valsartan18$174
Potassium Chloride17$154
Albuterol Sulfate HfaAlbuterol Sulfate11$143
Metoprolol Succinate12$133

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$515$16,55815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Asheboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →